PD Dr. ID: 6360691

Marianne Sinn

graph of relations
Affiliations

Publications

  1. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

    Zschaeck, S., Blümke, B., Wust, P., Kaul, D., Bahra, M., Riess, H., Klein, F., Sinn, M., Pelzer, U., Budach, V. & Ghadjar, P., 2017, In: PLOS ONE. 12, 10, p. e0186341

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  2. Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

    Wörmann, B., Bokemeyer, C., Burmeister, T., Köhne, C-H., Schwab, M., Arnold, D., Blohmer, J-U., Borner, M., Brucker, S., Cascorbi, I., Decker, T., de Wit, M., Dietz, A., Einsele, H., Eisterer, W., Folprecht, G., Hilbe, W., Hoffmann, J., Knauf, W., Kunzmann, V., Largiadèr, C. R., Lorenzen, S., Lüftner, D., Moehler, M., Nöthen, M. M., Pox, C., Reinacher-Schick, A., Scharl, A., Schlegelberger, B., Seufferlein, T., Sinn, M., Stroth, M., Tamm, I., Trümper, L., Wilhelm, M., Wöll, E. & Hofheinz, R-D., 23.10.2020, In: ONCOL RES TREAT. 43, 11, p. 628-636 9 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. Position of Scientific Oncological Societies Towards Biosimilar Antibodies

    Wörmann, B. & Sinn, M., 03.2019, In: BREAST CARE. 14, 1, p. 5-8 4 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  4. A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort Study

    von Grundherr, J., Elmers, S., Koch, B., Hail, L-A., Mann, J., Escherich, G., Bergelt, C., Samland, L., Jensen, W., Vettorazzi, E., Stark, M., Valentini, L., Baumann, F. T., Singer, S., Reer, R., Beller, R., Calaminus, G., Faber, J., Classen, C. F., Gebauer, J., Hilgendorf, I., Koehler, M., Puzik, A., Salzmann, N., Sander, A., Schiffmann, L., Sokalska-Duhme, M., Schuster, S., Kock-Schoppenhauer, A-K., Bokemeyer, C., Sinn, M., Stein, A., Dwinger, S. & Salchow, J., 04.03.2024, In: JAMA NETW OPEN. 7, 3, p. e242375

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study

    Vogel, A., Kasper, S., Bitzer, M., Block, A., Sinn, M., Schulze-Bergkamen, H., Moehler, M., Pfarr, N., Endris, V., Goeppert, B., Merx, K., Schnoy, E., Siveke, J. T., Michl, P., Waldschmidt, D., Kuhlmann, J., Geissler, M., Kahl, C., Evenkamp, R., Schmidt, T., Kuhlmann, A., Weichert, W. & Kubicka, S., 03.2018, In: EUR J CANCER. 92, p. 11-19 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care - a Randomized Pilot Study

    Ullrich, A., Wilde, S., Müller, V., Sinn, M., Gebhardt, C., Velthaus, J-L., Gerlach, C., Bokemeyer, C. & Oechsle, K., 2022, In: ONCOL RES TREAT. 45, 3, p. 118-129 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Einsatz von Neuen oralen Antikoagulanzien (NOAK) bei onkologischen Patienten

    Trappe, R. U., Sinn, M. & Riess, H., 09.2016, In: DEUT MED WOCHENSCHR. 141, 20, p. 1446-1450 5 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  8. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

    Tintelnot, J., Xu, Y., Lesker, T. R., Schönlein, M., Konczalla, L., Giannou, A. D., Pelczar, P., Kylies, D., Puelles, V. G., Bielecka, A. A., Peschka, M., Cortesi, F., Riecken, K., Jung, M., Amend, L., Bröring, T. S., Trajkovic-Arsic, M., Siveke, J. T., Renné, T., Zhang, D., Boeck, S., Strowig, T., Uzunoglu, F. G., Güngör, C., Stein, A., Izbicki, J. R., Bokemeyer, C., Sinn, M., Kimmelman, A. C., Huber, S. & Gagliani, N., 03.2023, In: NATURE. 615, 7950, p. 168-174 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma

    Stüben, B-O., Stuhlfelder, J., Kemper, M., Tachezy, M., Ghadban, T., Izbicki, J. R., Bokemeyer, C., Sinn, M., Karstens, K-F. & Reeh, M., 21.02.2022, In: CANCERS. 14, 4, 1084.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment

    Striefler, J. K., Sinn, M., Pelzer, U., Jühling, A., Wislocka, L., Bahra, M., Sinn, B. V., Denkert, C., Dörken, B., Oettle, H., Riess, H., Bläker, H. & Lohneis, P., 08.2016, In: PATHOL RES PRACT. 212, 8, p. 726-34 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

    Striefler, J. K., Riess, H., Lohneis, P., Bischoff, S., Kurreck, A., Modest, D. P., Bahra, M., Oettle, H., Sinn, M., Bläker, H., Denkert, C., Stintzing, S., Sinn, B. V. & Pelzer, U., 2021, In: FRONT ONCOL. 11, 670396.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I Investigation

    Striefler, J. K., Stieler, J. M., Neumann, C. C. M., Geisel, D., Ghadjar, P., Sinn, M., Malinka, T., Pratschke, J., Stintzing, S., Oettle, H., Riess, H. & Pelzer, U., 21.08.2022, In: J CLIN MED. 11, 16, 4905.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

    Stein, A., Paschold, L., Tintelnot, J., Goekkurt, E., Henkes, S-S., Simnica, D., Schultheiss, C., Willscher, E., Bauer, M., Wickenhauser, C., Thuss-Patience, P., Lorenzen, S., Ettrich, T., Riera-Knorrenschild, J., Jacobasch, L., Kretzschmar, A., Kubicka, S., Al-Batran, S-E., Reinacher-Schick, A., Pink, D., Sinn, M., Lindig, U., Hiegl, W., Hinke, A., Hegewisch-Becker, S. & Binder, M., 01.08.2022, In: JAMA ONCOL. 8, 8, p. 1150-1158 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Comparison of meniscal T1rho- and T2*-relaxation times in professional female volleyball players and healthy controls using 3T MRI: A pilot study

    Spink, C., Henes, F. O., Da Cruz, L., Sinn, M., Behzadi, C., Schoen, G., Welsch, G. H., Adam, G., Bannas, P. & Maas, K. J., 10.2022, In: EUR J RADIOL. 155, 110503.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Gallengangs- und Gallenblasenkarzinome: auf dem Weg zur personalisierten Therapie

    Sinn, M., Wege, H. & Stein, A., 04.2020, In: DEUT MED WOCHENSCHR. 145, 7, p. 442-446 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial

    Sinn, M., Sinn, B. V., Treue, D., Keilholz, U., Damm, F., Schmuck, R. B., Lohneis, P., Klauschen, F., Striefler, J. K., Bahra, M., Bläker, H., Bischoff, S., Pelzer, U., Oettle, H., Riess, H., Budczies, J. & Denkert, C., 15.07.2020, In: CLIN CANCER RES. 26, 14, p. 3732-3739 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results

    Sinn, M., Liersch, T., Riess, H., Gellert, K., Stübs, P., Waldschmidt, D., Lammert, F., Maschmeyer, G., Bechstein, W., Bitzer, M., Denzlinger, C., Hofheinz, R., Lindig, U., Ghadimi, M., Hinke, A., Striefler, J. K., Pelzer, U., Bischoff, S., Bahra, M. & Oettle, H., 10.2020, In: EUR J CANCER. 138, p. 172-181 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    Sinn, M., Bahra, M., Liersch, T., Gellert, K., Messmann, H., Bechstein, W., Waldschmidt, D., Jacobasch, L., Wilhelm, M., Rau, B. M., Grützmann, R., Weinmann, A., Maschmeyer, G., Pelzer, U., Stieler, J. M., Striefler, J. K., Ghadimi, M., Bischoff, S., Dörken, B., Oettle, H. & Riess, H., 10.10.2017, In: J CLIN ONCOL. 35, 29, p. 3330-3337 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

    Sinn, M., Sinn, B. V., Striefler, J. K., Lindner, J. L., Stieler, J. M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H. & Denkert, C., 01.11.2017, In: ANN ONCOL. 28, 11, p. 2900

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival

    Sinn, M., Bahra, M., Denecke, T., Travis, S., Pelzer, U. & Riess, H., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 248-57 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  21. Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group

    Sinn, M., Dälken, L., Striefler, J. K., Bischoff, S., Schweitzer, N., Pelzer, U., Dörken, B., Riess, H. & Stieler, J. M., 04.2016, In: PANCREAS. 45, 4, p. 601-5 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial

    Sinn, M., Riess, H., Sinn, B. V., Stieler, J. M., Pelzer, U., Striefler, J. K., Oettle, H., Bahra, M., Denkert, C., Bläker, H. & Lohneis, P., 08.2015, In: EUR J CANCER. 51, 12, p. 1546-54 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy

    Sinn, M., Ganeshan, R., Graf, R., Pelzer, U., Stieler, J. M., Striefler, J. K., Bahra, M., Wust, P. & Riess, H., 2014, In: SCI WORLD J. 2014, p. 452089

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

    Sinn, M., Denkert, C., Striefler, J. K., Pelzer, U., Stieler, J. M., Bahra, M., Lohneis, P., Dörken, B., Oettle, H., Riess, H. & Sinn, B. V., 11.11.2014, In: BRIT J CANCER. 111, 10, p. 1917-23 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma

    Sinn, B. V., Striefler, J. K., Rudl, M. A., Lehmann, A., Bahra, M., Denkert, C., Sinn, M., Stieler, J., Klauschen, F., Budczies, J., Weichert, W., Stenzinger, A., Kamphues, C., Dietel, M. & Riess, H., 05.2014, In: PANCREAS. 43, 4, p. 578-83 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161)

    Sinn, M., Nicolaou, A., Ricke, J., Podrabsky, P., Seehofer, D., Gebauer, B., Pech, M., Neuhaus, P., Dörken, B., Riess, H. & Hildebrandt, B., 09.08.2013, In: BMC GASTROENTEROL. 13, p. 125

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study

    Sinn, M., Nicolaou, A., Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H. & Hildebrandt, B., 08.2013, In: DIGEST DIS SCI. 58, 8, p. 2399-405 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

    Sinn, M., Bischoff, S., Nehls, O., Pelzer, U., von Weizsäcker, F., Kubicka, S., Stieler, J. M., Caca, K. & Riess, H., 2012, In: ONKOLOGIE. 35, 12, p. 755-60 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study

    Sinn, M., Striefler, J. K., Sinn, B. V., Sallmon, D., Bischoff, S., Stieler, J. M., Pelzer, U., Bahra, M., Neuhaus, P., Dörken, B., Denkert, C., Riess, H. & Oettle, H., 11.2013, In: J SURG ONCOL. 108, 6, p. 398-402 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL

    Seufferlein, T., Mayerle, J., Böck, S., Brunner, T., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A., Sinn, M., Tannapfel, A., Wedding, U. & Uhl, W., 11.2022, In: Z GASTROENTEROL. 60, 11, p. e812-e909

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  31. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL

    Seufferlein, T., Mayerle, J., Böck, S., Brunner, T., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A., Sinn, M., Tannapfel, A., Wedding, U. & Uhl, W., 06.2022, In: Z GASTROENTEROL. 60, 6, p. 991-1037 47 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  32. Risk estimation for biliary tract cancer: Development and validation of a prognostic score

    Schweitzer, N., Fischer, M., Kirstein, M. M., Berhane, S., Kottas, M., Sinn, M., Gonzalez-Carmona, M. A., Balta, Z., Weismüller, T. J., Strassburg, C. P., Reineke-Plaaß, T., Bektas, H., Manns, M. P., Johnson, P., Weinmann, A. & Vogel, A., 12.2017, In: LIVER INT. 37, 12, p. 1852-1860 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. 71/m in reduziertem Allgemeinzustand mit Sklerenikterus

    Schönrock, M. & Sinn, M., 24.08.2021, In: ONKOLOGE. 2021, 27 supplement issue 1, p. 109-113

    Research output: SCORING: Contribution to journalSCORING: Journal articleEducation

  34. Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

    Schönlein, M., Wrage, V., Ghandili, S., Mellinghoff, S. C., Brehm, T. T., Leypoldt, L. B., Utz, N., Schrader, R. M., Alsdorf, W., Börschel, N., Bußmann, L., Schönrock, M., Perlick, D., Schön, G., Verpoort, K., Lütgehetmann, M., Schulze Zur Wiesch, J., Weisel, K. C., Bokemeyer, C., Schafhausen, P. & Sinn, M., 13.06.2022, In: CANCER CELL. 40, 6, p. 581-583 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  35. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma

    Schnapauff, D., Denecke, T., Grieser, C., Collettini, F., Colletini, F., Seehofer, D., Sinn, M., Banzer, J., Lopez-Hänninen, E., Hamm, B., Wust, P. & Gebauer, B., 06.2012, In: CARDIOVASC INTER RAD. 35, 3, p. 581-7 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors - the randomized phase II Motivate AYA - MAYA trial

    Salchow, J., Koch, B., Mann, J., von Grundherr, J., Elmers, S., Dwinger, S., Escherich, G., Vettorazzi, E., Reer, R., Sinn, M., Baumann, F., Bokemeyer, C., Stein, A. & Jensen, W., 08.2021, In: CLIN REHABIL. 35, 8, p. 1164-1174 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms – Kurzversion 2.00 – Juni 2021, AWMF-Registernummer: 032-053OL

    Sabrina, V., Michael, B., Jörg, A., Peter, B., Wolf, B., Susanne, B., Thomas, B., Frank, D., Matthias, E., Markus, F., Christian, L. F., Paul, F., Andreas, G., Eleni, G., Martin, G., Elke, H., Thomas, H., Ralf-Thorsten, H., Wolf-Peter, H., Peter, H., Achim, K., Gabi, K., Jürgen, K., David, K., Frank, L., Hauke, L., Thomas, L., Philipp, L., Andreas, M., Alexander, M., Oliver, M., Silvio, N., Huu Phuc, N., Johann, O., Karl-Jürgen, O., Philipp, P., Kerstin, P., Philippe, P., Thorsten, P., Mathias, P., Ruben, P., Jürgen, P., Jutta, R., Peter, R., Johanna, R., Ulrike, R., Elke, R., Barbara, S., Peter, S., Irene, S., Andreas, S., Dietrich, V. S., Daniel, S., Marianne, S., Alexander, S., Andreas, S., Nadine, S., Christian, S., Andrea, T., Anne, T., Jörg, T., Ingo, V. T., Reina, T., Arndt, V., Thomas, V., Hilke, V., Frank, W., Oliver, W., Heiner, W., Henning, W., Dane, W., Christian, W., Marcus-Alexander, W., Peter, G. & Nisar, M., 01.2022, In: Z GASTROENTEROL. 60, 1, p. 81-107 27 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  38. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms

    Sabrina, V., Michael, B., Jörg, A., Peter, B., Wolf, B., Susanne, B., Thomas, B., Frank, D., Matthias, E., Markus, F., Christian, L. F., Paul, F., Andreas, G., Eleni, G., Martin, G., Elke, H., Thomas, H., Ralf-Thorsten, H., Wolf-Peter, H., Peter, H., Achim, K., Gabi, K., Jürgen, K., David, K., Frank, L., Hauke, L., Thomas, L., Philipp, L., Andreas, M., Alexander, M., Oliver, M., Silvio, N., Huu Phuc, N., Johann, O., Karl-Jürgen, O., Philipp, P., Kerstin, P., Philippe, P., Thorsten, P., Mathias, P., Ruben, P., Jürgen, P., Jutta, R., Peter, R., Johanna, R., Ulrike, R., Elke, R., Barbara, S., Peter, S., Irene, S., Andreas, S., Dietrich, V. S., Daniel, S., Marianne, S., Alexander, S., Andreas, S., Nadine, S., Christian, S., Andrea, T., Anne, T., Jörg, T., Ingo, V. T., Reina, T., Arndt, V., Thomas, V., Hilke, V., Frank, W., Oliver, W., Heiner, W., Henning, W., Dane, W., Christian, W., Marcus-Alexander, W., Peter, G. & Nisar, M., 01.2022, In: Z GASTROENTEROL. 60, 1, p. e56-e130

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  39. Effects of Exercise Training on Patient-Specific Outcomes in Pancreatic Cancer Patients: A Scoping Review

    Rosebrock, K., Sinn, M., Uzunoglu, F. G., Bokemeyer, C., Jensen, W. & Salchow, J., 18.12.2023, In: CANCERS. 15, 24, 5899.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  40. Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review

    Riess, H., Habbel, P., Jühling, A., Sinn, M. & Pelzer, U., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 258-70 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  41. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement

    Pijnappel, E. N., Suurmeijer, J. A., Koerkamp, B. G., Kos, M., Siveke, J. T., Salvia, R., Ghaneh, P., van Eijck, C. H. J., van Etten-Jamaludin, F. S., Abrams, R., Brasiuniene, B., Büchler, M. W., Casadei, R., van Laethem, J-L., Berlin, J., Boku, N., Conroy, T., Golcher, H., Sinn, M., Neoptolemos, J. P., van Tienhoven, G., Besselink, M. G., Wilmink, J. W. & van Laarhoven, H. W. M., 01.06.2022, In: JAMA ONCOL. 8, 6, p. 929-937 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis

    Pelzer, U., Wislocka, L., Jühling, A., Striefler, J., Klein, F., Roemmler-Zehrer, J., Sinn, M., Denecke, T., Bahra, M. & Riess, H., 09.2018, In: EUR J CANCER. 100, p. 85-93 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

    Pelzer, U., Opitz, B., Deutschinoff, G., Stauch, M., Reitzig, P. C., Hahnfeld, S., Müller, L., Grunewald, M., Stieler, J. M., Sinn, M., Denecke, T., Bischoff, S., Oettle, H., Dörken, B. & Riess, H., 20.06.2015, In: J CLIN ONCOL. 33, 18, p. 2028-34 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy

    Pelzer, U., Hilbig, A., Sinn, M., Stieler, J., Bahra, M., Dörken, B. & Riess, H., 2013, In: FRONT ONCOL. 3, p. 155

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Blood group determinates incidence for pancreatic cancer in Germany

    Pelzer, U., Klein, F., Bahra, M., Sinn, M., Dörken, B., Neuhaus, P., Meyer, O. & Riess, H., 2013, In: FRONT PHYSIOL. 4, p. 118

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial

    Pelzer, U., Hilbig, A., Stieler, J. M., Bahra, M., Sinn, M., Gebauer, B., Dörken, B. & Riess, H., 19.03.2014, In: BMC CANCER. 14, p. 204

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Multimodale Therapie des Pankreaskarzinoms

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 01.2014, In: INTERNIST. 55, 1, p. 31-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Primäre medikamentöse Thromboembolieprophylaxe bei ambulanten Patienten mit fortgeschrittenem Pankreaskarzinom unter Chemotherapie?

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 10.2013, In: DEUT MED WOCHENSCHR. 138, 41, p. 2084-8 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

    Pape, U-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Müller, L., Burkhard, O., Caca, K., Heeg, S., Büchner-Steudel, P., Rodriguez-Laval, V., Kühl, A. A., Arsenic, R., Jansen, H., Treasure, P. & Utku, N., 27.10.2020, In: CANCERS. 12, 11

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial: outcomes from the CONKO-003 trial

    Oettle, H., Riess, H., Stieler, J. M., Heil, G., Schwaner, I., Seraphin, J., Görner, M., Mölle, M., Greten, T. F., Lakner, V., Bischoff, S., Sinn, M., Dörken, B. & Pelzer, U., 10.08.2014, In: J CLIN ONCOL. 32, 23, p. 2423-9 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next